Off-label use of low dose rituximab may be a valuable option for management of pemphigus, experience at a Victorian hospital suggests. Clinicians at the Department of Dermatology, Royal Melbourne Hospital have described how some patients have achieved control of pemphigus within a month after receiving ultra-low doses of rituximab. In their report, published in the ...
Ultra-low dose rituximab shows promise for pemphigus
By Michael Woodhead
19 Oct 2021